• News
  • SAN DIEGO
  • Finance

Vital Therapies prices IPO

Vital Therapies Inc. (Nasdaq: VTL) announced Wednesday evening the pricing of its initial public offering of 4.5 million shares of common stock at a price to the public of $12 per share.

The San Diego-based biotherapeutic company develops a cell-based therapy targeting the treatment of acute liver failure. The company will begin trading on the Nasdaq Global Market today, under the ticker symbol "VTL."

Vital Therapies has granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock, according to the announcement. BofA Merrill Lynch and Credit Suisse Securities LLC are acting as joint book-running managers for the offering. William Blair & Company LLC and Canaccord Genuity Inc. are acting as co-managers.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on April 16.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Vital Therapies Inc.

Company Website

105010 Avenue of Science Ste., 200
San Diego , CA 92128

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
VTL
6.79
  0.28  
+ 4.30%
1,753,912,000
29.67
2.81

Vital Therapies Inc. Executive(s):

Terry Winters, Ph.D.

  • Chief Executive Officer, Co-Chairman
Subscribe Today!